Subcutaneous Biologic Market
Subcutaneous Biologic Market Study by Cancer, Crohn’s Disease, Cardiovascular Disorders, Diabetes, Multiple Sclerosis, Psoriasis, Rheumatoid Arthritis, and Others From 2024 to 2034
Analysis of Subcutaneous Biologic Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Subcutaneous Biologic Market Outlook (2024 to 2034)
The global subcutaneous biologic market is analyzed to reach a valuation of US$ 1.87 billion in 2024 and is further projected to touch US$ 5.41 billion by 2034-end. Demand is evaluated to expand at a CAGR of 11.2% between 2024 to 2034.
The need for biological medicines is driven by the increasing prevalence of chronic illnesses, such as diabetes, rheumatoid arthritis, and different types of cancer. Subcutaneous biologics provide efficient means of treating several conditions, promoting patient compliance, and enhancing health results. Self-administering therapies at home are becoming more popular among patients than ones that need hospital visits for intravenous infusions.
More comfort and convenience are made possible by subcutaneous delivery, which improves patient satisfaction and compliance. Pre-filled syringes, auto-injectors, and wearable technology are examples of innovations in drug delivery systems that have enhanced the efficacy, convenience, and safety of subcutaneous biologic administration.
North America is projected to account for 34.4% of the global market share in 2024. The market in North America is continuously showing bullish sentiments because of its strong healthcare system and high rate of chronic illness. Other than this, several biopharmaceutical companies and academic institutes that specialize in advanced biologic medicines are located in the region, which is further driving market expansion.
Based on indication, the cancer segment is analyzed to hold 33.4% of the overall market revenue in 2024 due to the increasing number of patients with different types of cancer and this is also driving up emphasis on new therapeutic approaches. Subcutaneous biologics, such as targeted treatments and monoclonal antibodies provide efficient substitutes for intravenous infusions in clinical settings, allowing patients to self-administer at home and improving patient compliance.
By delivery system, the syringe category is estimated to lead with 39.6% of the revenue share in 2024 because of its convenience of use, safety characteristics, and adaptability. Syringes are a desirable option for at-home self-administration of biologic medicines because of their well-known simple administration procedure.
| Report Attributes | Details |
|---|---|
| Subcutaneous Biologic Market Size (2024E) | US$ 1.87 Billion |
| Forecasted Market Value (2034F) | US$ 5.41 Billion |
| Global Market Growth Rate (2024 to 2034) | 11.2% CAGR |
| North America Market Share (2024E) | 34.4% |
| Western Europe Market Value (2024E) | US$ 428.49 Million |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 15.3% CAGR |
| Cancer Segment Value (2034F) | US$ 2.14 Billion |
| Syringe Segment Value (2034F) | US$ 2.11 Billion |
| Key Companies Profiled | Abbott Laboratories; Pfizer Inc.; Genentech Inc.; Novartis AG; Biogen Idec; AbbVie, Inc.; F. Hoffmann-La Roche AG; Bristol-Myers Squibb; Eisai, Inc.; Takeda Pharmaceuticals Ltd.; Alnylam Pharmaceuticals; Bayer AG; GlaxoSmithKline; Sanofi S.A.; Boston Pharmaceuticals |
Biologics are all pharmaceutical products developed using a biological process. Biologic products include drugs manufactured from various living organisms with the help of biotechnology. Subcutaneous biologics consists of sugar, nucleic acid, protein, or a combination of these substances. Subcutaneous biologics include vaccines, blood and its components, recombinant proteins, and others.
Subcutaneous biologics are the most advanced therapeutics used for the treatment of several diseases like cancer, diabetes, multiple sclerosis, psoriasis, and many more. Subcutaneous biologics are injected/infused so that the proteins are not digested or inactivated early. Whereas administration of subcutaneous biologics does not require highly skilled personnel as compared to intravenous biologics According to the International Diabetes Federation, 463 million suffered from diabetes in 2019 worldwide and is estimated to reach 578 million by 2030.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Subcutaneous Biologics Market: Drivers and Restraints
The rising prevalence of chronic disorders increases product demand. An increasing rate of treatment adoption rate is expected to boost subcutaneous biologics market growth. The gradually increasing level of awareness among the general population about several prevailing disorders propels the market growth. The rise in research and development activities for subcutaneous biologics will lead to the expansion of the global market. For instance, in June 2020 U.S. Food and Drug Administration (FDA) approved Genentech Inc.
For their subcutaneous biologic named Phesgo for treatment of HER-2 breast cancer. An increasing trend of self-medication leads to subcutaneous biologics market growth. Biologics sometimes lead to allergic reactions. The strict regulatory requirement for approval of subcutaneous biologics challenges the business growth.
Subcutaneous Biologics Market: Overview
Cancer and Diabetes are expected to contribute significantly to the subcutaneous biologics market in the coming decade with increasing prevalence. The increasing rate of diagnosis will also lead to hormonal disorders having a significant contribution to the market. Automatic injectors are estimated to observe a rise in demand during the forecast period. Whereas, based on distribution channels hospital pharmacies segment holds the majority of the revenue share.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Subcutaneous Biologics Market: Regional-Wise Outlook
North America tends to be the leading region in the subcutaneous biologics market with the highest rate of development and commercialization of pharmaceutical products. Europe will have a significant contribution with a rising geriatric population and patients suffering from chronic disorders. Asia-Pacific region is estimated to have an exponential rise in growth rate with a large number of entrants and domestic players in the region. The Middle East and Africa will have the lowest growth rate due to poor economic conditions and the unavailability of advanced diagnostic technology.
Subcutaneous Biologics Market: Key players
Some key players contributing global subcutaneous biologics industry are Abbott Laboratories, Pfizer Inc., Genentech Inc., Novartis AG, Biogen Idec, AbbVie, Inc., F. Hoffmann-La Roche AG, Bristol-Myers Squibb, Eisai, Inc., Takeda Pharmaceuticals Ltd., Alnylam Pharmaceuticals, Bayer AG, GlaxoSmithKline, Sanofi S.A., Boston Pharmaceuticals and others.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report on the Subcutaneous Biologics Market covers an exhaustive analysis on
- Market Segments
- Market Dynamics
- Historical Actual Market Size, 2019 to 2023
- Market Size & Forecast 2024 to 2034
- Supply & Demand Value Chain
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
- Market Drivers and Restraints
Regional analysis for Subcutaneous Biologics Market includes
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Report on Subcutaneous Biologics Market highlights
- Shifting industry dynamics
- In-depth market segmentation
- Historical, current, and projected industry size
- Recent industry trends
- Key competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Segmentation of Subcutaneous Biologic Market Research
-
By Indication :
- Cancer
- Crohn’s Disease
- Cardiovascular Disorders
- Diabetes
- Multiple Sclerosis
- Psoriasis
- Rheumatoid Arthritis
- Metabolic Disorders
- Growth Hormone Deficiency
-
By Delivery System :
- Syringes
- Wearable Injectors
- Automatic Injectors
- Implants
- Pen Injectors
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Drug Stores
- Online Pharmacies
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Indication 6.2. Delivery System 6.3. Distribution Channel 7. Global Market Analysis and Forecast, By Indication 7.1. Cancer 7.2. Crohn’s disease 7.3. Cardiovascular disorders 7.4. Diabetes 7.5. Multiple sclerosis 7.6. Psoriasis 7.7. Rheumatoid Arthritis 7.8. Metabolic disorders 7.9. Growth hormone deficiency 7.10. Others 8. Global Market Analysis and Forecast, By Delivery System 8.1. Syringe 8.2. Wearable injector 8.3. Automatic injector 8.4. Implants 8.5. Pen injectors 8.6. Others 9. Global Market Analysis and Forecast, By Distribution Channel 9.1. Hospital pharmacies 9.2. Retail pharmacies 9.3. Drug stores 9.4. Online pharmacies 10. Global Market Analysis and Forecast, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. East Asia 10.6. South Asia & Pacific 10.7. MEA 11. North America Sales Analysis and Forecast, by Key Segments and Countries 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries 17. MEA Sales Analysis and Forecast, by Key Segments and Countries 18. Sales Forecast by Indication, Delivery System, and Distribution Channel for 30 Countries 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 20. Company Profile 20.1. Amgen Inc. 20.2. Eli Lilly and Company 20.3. Pfizer Inc. 20.4. GlaxoSmithKline plc 20.5. Roche Holding AG 20.6. Sanofi S.A. 20.7. Novartis AG 20.8. Merck & Co., Inc. 20.9. AbbVie Inc. 20.10. Bristol Myers Squibb
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Indication
Table 3: Global Market US$ Mn Forecast by Delivery System
Table 4: Global Market US$ Mn Forecast by Distribution Channel
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Indication
Table 7: North America Market US$ Mn Forecast by Delivery System
Table 8: North America Market US$ Mn Forecast by Distribution Channel
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Indication
Table 11: Latin America Market US$ Mn Forecast by Delivery System
Table 12: Latin America Market US$ Mn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Indication
Table 15: Western Europe Market US$ Mn Forecast by Delivery System
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Indication
Table 19: Eastern Europe Market US$ Mn Forecast by Delivery System
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Indication
Table 23: East Asia Market US$ Mn Forecast by Delivery System
Table 24: East Asia Market US$ Mn Forecast by Distribution Channel
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Indication
Table 27: South Asia & Pacific Market US$ Mn Forecast by Delivery System
Table 28: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Indication
Table 31: MEA Market US$ Mn Forecast by Delivery System
Table 32: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Delivery System
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the subcutaneous biologic market in 2024?
The global market for subcutaneous biologics is estimated at US$ 1.87 billion in 2024.
What is the future of subcutaneous biologics?
Worldwide demand for subcutaneous biologics is projected to reach US$ 5.41 billion by 2034.
Subcutaneous Biologic Market